Menopause News

Currently, cognitive behavioral therapy for insomnia is the gold standard treatment for sleep disturbances associated with menopause, and research is underway to better target neurons responsible for sleep disturbances.

For midlife women, better cognitive function — specifically ability, attention, processing speed and executive function — was associated with a lower likelihood of lower urinary tract symptoms, researchers reported in Menopause.

Clinics with vs. without Menopause Society Certified Practitioners were more likely to adhere to guidelines and not advertise compounded or bioidentical hormones, hormones for youthful appearance or weight loss or recommend hormone testing.

Cleveland Clinic has launched a holistic health center focused exclusively on caring for midlife women, addressing a wide range of needs from osteoporosis and breast health to CVD prevention and the menopause transition.

Hormone replacement therapy was associated with improved disease symptoms, measured by the physician global assessment score, in a cohort of postmenopausal women with inflammatory bowel disease, according to data.

Fezolinetant was associated with significant improvements in patient-reported vasomotor symptom frequency and menopause-specific quality of life, according to an analysis published in Menopause.

BOSTON — Midlife women reporting bothersome hot flashes are more likely to receive a diagnosis of metabolic dysfunction-associated steatotic liver disease regardless of hormone therapy use, according to a speaker.

Hormone replacement therapy may render the skin of postmenopausal women both more prone to inflammation and more capable of repairing itself, according to a study.

PHILADELPHIA — Consistently missed periods brought on by intense exercise, disordered eating or stress in young women can lead to multiple consequences, including endothelial dysfunction and increased CVD risk, according to a speaker.

BOSTON — People with primary ovarian insufficiency have higher risk for breast cancer and borderline increased risk for ovarian cancer compared with the general population, and risks for some cancers extend to their relatives, data show.